Chemo or Provenge - All out war vs precision targeting
There is another stumbling block to the uptake of Provenge other than the reimbursement issues; Provenge is a threat to the chemo industry franchise. Prescribing doctors are in the loop on that end. If immunotherpies become the treatment of choice over time a huge revenue stream dries up on their end from the chemo companies. Not that it would happen overnight, but the longer term threat of a game changer is palpable.